Dose standardisation of anticancer drugs
- 14 January 2011
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 33 (2) , 221-228
Abstract
Objective of the study Body size based dosing is often used for prescribing anticancer drugs. However the scientific and the clinical rationales of this historical method have recently been criticized. As a result, alternative dosing strategies have been suggested, as flat-fixed dosing regimens, but not implemented in routine practice. Dose standardisation is a first step in order to rationalise chemotherapy dose calculation. A new method, derived from dose-banding, was developed, taking into account prescription and economic criteria. Setting Feasibility and interest of this concept were studied in two French cancer centres Institut Curie and Hôpital Saint-Louis. Main outcome measures The aim of our study was to assess dose standardisation of expensive anticancer drugs in objectives of quality and economy. Method Nine candidate drugs were selected and standardized rounded doses (SRD) were proposed. To determine the specific standard doses of these two centres, two theoretical and practical methods were applied, and then, their results were compared. For each anticancer drug the objective was to fix SRD in order to cover all the doses most frequently prescribed. Results It has been possible to propose SRD for six of the nine drugs. These SRD have been implemented with the agreement of the medical staff. These doses are, whenever possible, rounded to the nearest vial size, or correspond to a combination of the different strength of the commercial drug. Conclusion Our study shows that dose standardisation is a help to optimise the productivity and improve the organisation of the preparation unit.Keywords
This publication has 28 references indexed in Scilit:
- Dose-banding of carboplatin: rationale and proposed banding schemeJournal of Oncology Pharmacy Practice, 2007
- Stability issues of parenteral chemotherapy drugsJournal of Oncology Pharmacy Practice, 2007
- Evaluation of an Alternate Dosing Strategy for Cisplatin in Patients With Extreme Body Surface Area ValuesJournal of Clinical Oncology, 2006
- Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy processInternational Journal for Quality in Health Care, 2005
- I don't underdose my patients…do I?The Lancet Oncology, 2005
- Practitioners? sources of clinical information on complementary and alternative medicine in oncologySupportive Care in Cancer, 2004
- Implications of dose rounding of chemotherapy to the nearest vial sizeSupportive Care in Cancer, 2003
- Rationalisation of chemotherapy services in the University Hospital Birmingham National Health Science TrustJournal of Oncology Pharmacy Practice, 1998
- Predictors of body surface areaJournal of Clinical Anesthesia, 1992
- Is Dose Normalization to Weight or Body Surface Area Useful in Adults?JNCI: Journal of the National Cancer Institute, 1990